Showing results (11-20 of 196) with videos related to
Sort By:
Pageof 20
Methodist Debakey Cardiovascular Journal|August 15, 2012
Next-generation transcatheter heart valves: current trials in Europe and the USAJan-Malte Sinning, Nikos Werner, Georg Nickenig, et al.The Thoracic and Cardiovascular Surgeon|February 11, 2017
New Mitral Annuloplasty Ring Enables Oversizing of Transcatheter Heart Valve and Prevents Central or Paravalvular LeakageGeorg Daniel Duerr, Jan-Malte Sinning, Armin Georg Welz, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 31, 2012
Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stentingJan-Malte Sinning, Viktoria Stoffel, Eberhard Grube, et al.Cardiovascular Intervention and Therapeutics|August 10, 2019
Percutaneous interventions for mitral and tricuspid heart valve diseasesNoriaki Tabata, Atsushi Sugiura, Kenichi Tsujita, et al.Heart (British Cardiac Society)|October 5, 2010
Prognosis of octogenarians with severe aortic valve stenosis at high risk for cardiovascular surgeryRobert Schueler, Christoph Hammerstingl, Jan-Malte Sinning, et al.European Heart Journal Supplements : Journal of the European Society of Cardiology|December 15, 2022
Optimal bail-out and complication management strategies in protected high-risk percutaneous coronary intervention with the ImpellaJan-Malte Sinning, Karim Ibrahim, Jörg Schröder, et al.The Journal of Invasive Cardiology|October 1, 2019
Provisional Closure of an Iatrogenic Atrial Septal Defect for Shunt Reversal After Transcatheter Treatment of Tricuspid RegurgitationAtsushi Sugiura, Marcel Weber, Jan-Malte Sinning, et al.European Heart Journal Supplements : Journal of the European Society of Cardiology|December 15, 2022
Defining the optimal revascularization strategy during protected high-risk procedures with ImpellaJan-Malte Sinning, Fadi Al-Rashid, Karim Ibrahim, et al.European Heart Journal|December 28, 2010
Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomesJan-Malte Sinning, Jan Losch, Katrin Walenta, et al.Interventional Cardiology (London, England)|March 29, 2018
Permanent Pacemaker Implantation after TAVR - Predictors and Impact on OutcomesMarcel Weber, Jan-Malte Sinning, Christoph Hammerstingl, et al.Pageof 20